Intravenous immunologlobulin for Guillain-Barré syndrome: How effective?

Journal of Child Neurology

Volumn 21, Issue 11, 2006, Pages 972-974

  Ali Tasdemir, Haydar ^a   Dilber, Cengiz ^b   Kanber, Yilmaz ^c   Uysal, Serap ^d  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^c Kirikkale State Hospital   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846302384     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738060210110701     Document Type: Article

References (27)

1. Asbury AK, Cornblath DR: Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; Suppl:S21-S24.
2. Zaferious DI, Kontopoulos EE, Katzos GS, et al: Single dose immunoglobulin therapy for childhood Guillain-Barré syndrome. Brain Dev 1997;19:323-325.
3. Ropper AH: Severe acute Guillain-Barré syndrome. Neurology 1986; 36:429-432.
4. Cole GF, Matthew DJ: Prognosis in severe Guillain-Barré syndrome. Arch Dis Child 1987;62:288-291.
5. Briscoe DM, McMenamin JB, O'Donohoe NV: Prognosis in Guillain-Barré syndrome. Arch Dis Child 1987;62:733-735.
6. Bradshaw DY, Jones HR Jr: Guillain-Barré syndrome in children: Clinical course, electrodiagnosis, and prognosis. Muscle Nerve 1992; 15:500-506.
7. Lawn ND, Wijdicks EF: Fatal Guillain-Barré syndrome. Neurology 1999;52:635-638.
8. Epstein MA, Sladky JT: The role of plasmapheresis in childhood Guillain-Barré syndrome. Ann Neurol 1990;28:65-69.
9. Vajsar J, Sloane A, Wood E, Murphy EG: Plasmapheresis vs intravenous immunoglobulin treatment in childhood Guillain-Barré syndrome. Arch Pediatr Adolesc Med 1994;148:1210-1212.
10. Wang CH, Trifiletti R, Gold AP, De Vivo DC: Plasma exchange versus intravenous immunoglobulin as treatment for childhood-onset Guillain-Barré syndrome, abstract. Ann Neurol 1992;32:440.
11. Kanra G, Ozon A, Vajsar J, et al: Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome. Eur J Paediatr Neurol 1997;1:7-12.
12. Eberle E, Brink J, Azen S, White D: Early predictors of incomplete recovery in children with Guillain-Barré polyneuritis. J Pediatr 1975; 86:356-359.
13. Vajsar J, Fehlings D, Stephens D: Long-term outcome in children with Guillain-Barré syndrome. J Pediatr 2003;142:305-309.
14. Jones HR: Childhood Guillain-Barré syndrome: Clinical presentation, diagnosis, and therapy. J Child Neurol 1996;11:4-12.
15. Hankey GJ: Guillain-Barre syndrome in Western Australia, 1980-1985. Med J Aust 1987;146:130-133.
16. Lamont PJ, Johnston HM, Berdoukas VA: Plasmapheresis in children with Guillain-Barré syndrome. Neurology 1991;41:1928-1931.
17. Jansen PW, Perkin RM, Ashwal S: Guillain-Barré syndrome in childhood: Natural course and efficacy of plasmapheresis. Pediatr Neurol 1993;9:16-20.
18. Freezer NJ, Robertson CF: Tracheostomy in children with Guillain Barré syndrome. Crit Care Med 1990;18:1236-1238.
19. Kleyweg RP, van der Meche FG, Loonen MC, et al: The natural history of the Guillain-Barré syndrome in 18 children and 50 adults. J Neurol Neurosurg Psychiatry 1989;52:853-856.
20. Ouvrier RA, McLeod JG, Pollard JD: Peripheral neuropathy in childhood, in Procopis PG, Rapin I (eds): The International Review of Child Neurology, New York, Raven Press, 1990, 39-49.
21. Sakakihara Y, Kamoshita S: Age-associated changes in the symptomatology of Guillain-Barré syndrome in children. Dev Med Child Neurol 1991;33:611-616.
22. Hirano Y, Osawa M, Ohya T, et al: Guillain-Barre syndrome in children: Questionnaire survey on therapies and clinical outcomes. Shonika Rinsyo (Tokyo) 2000;53:77-85.
23. Graf WD, Katz JS, Eder DN, et al: Outcome in severe pediatric Guillain-Barré syndrome after immunotherapy or supportive care. Neurology 1999;52:1494-1497.
24. Ammache Z, Afifi AK, Brown CK, Kimura J: Childhood Guillain-Barré syndrome: Clinical and electrophysiologic features predictive of outcome. J Child Neurol 2001;16:477-483.
25. Reisin RC, Pociecha J, Rodriguez E, et al: Severe Guillain-Barré syndrome in childhood treated with human immune globulin. Pediatr Neurol 1996;14:308-312.
26. Korinthenberg R, Monting JS: Natural history and treatment effects in Guillain-Barré syndrome: A multicenter study. Arch Dis Child 1996; 74:281-287.
27. Yata J, Nihei K, Ohya T, et al: High-dose immunoglobulin therapy for Guillain-Barré syndrome in Japanese children. Pediatr Int 2003;45: 543-549.